Firebrick Pharma Limited (ASX:FRE – Get Free Report) insider Peter Molloy purchased 500,000 shares of Firebrick Pharma stock in a transaction dated Thursday, June 27th. The shares were bought at an average price of A$0.06 ($0.04) per share, for a total transaction of A$28,500.00 ($19,000.00).
Firebrick Pharma Price Performance
Firebrick Pharma Company Profile
Firebrick Pharma Limited engages in the development and partnering of broad-spectrum antimicrobial spray for the treatment of common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.
Recommended Stories
- Five stocks we like better than Firebrick Pharma
- What is an Earnings Surprise?
- RXO Shares Surge Following New Acquisition Deal
- Basic Materials Stocks Investing
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- How to Buy Cheap Stocks Step by Step
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Firebrick Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firebrick Pharma and related companies with MarketBeat.com's FREE daily email newsletter.